Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease
about
Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 InfectionDNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft RejectionRecent advances in preclinical model systems for papillomaviruses.
P2860
Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Optimization of heterologous D ...... illomavirus-associated disease
@ast
Optimization of heterologous D ...... illomavirus-associated disease
@en
type
label
Optimization of heterologous D ...... illomavirus-associated disease
@ast
Optimization of heterologous D ...... illomavirus-associated disease
@en
prefLabel
Optimization of heterologous D ...... illomavirus-associated disease
@ast
Optimization of heterologous D ...... illomavirus-associated disease
@en
P2093
P2860
P1433
P1476
Optimization of heterologous D ...... illomavirus-associated disease
@en
P2093
Andrew Yang
Benjamin Yang
Chien-Fu Hung
Cory Brayton
Jessica Jeang
Joshua W Wang
Richard B S Roden
Shiwen Peng
P2860
P2888
P356
10.1186/S13578-016-0080-Z
P577
2016-02-25T00:00:00Z
P5875
P6179
1032596087